<DOC>
	<DOCNO>NCT01537705</DOCNO>
	<brief_summary>A clinical outcome study measure reduction pain numbness experience four type peripheral neuropathy patient 60 day administration amino acid formulation .</brief_summary>
	<brief_title>A Clinical Outcomes Study Measure Reduction Pain Numbness During Administration Amino Acid Formulation Subjects Diagnosed With Peripheral Neuropathy</brief_title>
	<detailed_description>Peripheral neuropathy disorder peripheral nervesâ€”the motor , sensory autonomic nerve connect spinal cord muscle , skin internal organ . It usually affect hands foot , cause weakness , numbness , tingle pain . Peripheral neuropathy 's course variable ; come go , slowly progress many year , become severe debilitate . Peripheral neuropathy common estimate upwards 20 million Americans suffer illness . It occur age , common among elderly patient . In l999 , survey find 8-9 % Medicare recipients peripheral neuropathy primary secondary diagnosis annual cost Medicare exceed $ 3.5 billion . Approximately 30 % peripheral neuropathy case link diabetes . Other common cause neuropathy include autoimmune disorder , tumor , hereditary condition , nutritional imbalance , infection toxin . Another 30 % peripheral neuropathy term `` idiopathic '' cause unknown . Pain particular complex process initiate pain-inducing noxious stimulus interact pain receptor ( nociceptors ) trigger series action potential transmit neurotransmitter peripheral afferent neuron spinal cord high nerve center brain . The study intervention classify medical food must use active ongoing supervision physician . Medical food develop address different alter physiologic requirement may exist individual distinctive nutritional need arise metabolic disorder , chronic disease , injury , premature birth associate inflammation medical condition , well pharmaceutical therapy . All ingredient include study intervention classify generally recognize safe ( GRAS ) United States Food Drug Administration ( FDA ) . To qualify GRAS status , substance add food , include medical food , support data demonstrate safe consume amount food , typically ingested prescribed . The study intervention proprietary blend amino acid antioxidant design target cellular process involve management peripheral neuropathy symptom . All ingredient supply small milligram quantity allow safe flexible dosing .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>1 . Confirmation peripheral neuropathy diagnosis physician . 2 . Subjects able read understand English . 3 . Subjects willing commit study visit duration administration . 4 . Male nonpregnant/lactating female , age 18 75 . 1 . Subjects hospitalize within last 30 day . 2 . History nerve surgery . 3 . Currently take medical food . 4 . Existing serious medical condition ( i.e . severe heart , liver kidney disease ) . 5 . Subjects measure creatinine great 2.5 , ALT AST great three time normal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Medical food</keyword>
	<keyword>Neuropathy</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Neuropathic Pain</keyword>
</DOC>